Chlorhexidine Gluconate (CHG) Applicators, Surgical
ID: MN-2407-40Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORTPHILADELPHIA, PA, 19111, USA

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/89b67cb199a84270b5e1ca14c51afd16/view
Timeline
    Description

    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors to qualify for a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Surgical. This initiative aims to standardize the procurement of these medical supplies for Military Treatment Facilities (MTFs) and operational units across the Armed Forces, with an estimated annual sales volume of approximately $908,392. Vendors must meet stringent compliance criteria, including having a DAPA number, an active CAGE Code, and ensuring that products are manufactured in Trade Agreements Act (TAA) compliant countries, while also adhering to FDA regulations. Interested vendors must submit their QSL Package Worksheet and supporting documentation by 5 PM Philadelphia time on November 14, 2024, to Ms. Andrea L. Honesto at andrea.l.honesto.ctr@health.mil, with the QSL expected to be established by December 14, 2024.

    Point(s) of Contact
    Ms. Andrea L. Honesto
    andrea.l.honesto.ctr@health.mil
    David Sheaffer MMESO South Team Leader Contractor
    david.v.sheaffer.ctr@health.mil
    Files
    Title
    Posted
    QSL Announcement MN-2407-40 CHG APPLICATORS SURGICAL.docx
    The Defense Health Agency (DHA) Medical Logistics Directorate is seeking vendors through a Sources Sought notification for inclusion in a Qualified Suppliers Listing (QSL) for Chlorhexidine Gluconate (CHG) Applicators, Surgical. This initiative is not a price quote request but aims to standardize the procurement of these applicators for Military Treatment Facilities (MTFs) and the operational units of the Armed Forces. Interested vendors must provide detailed documentation, including a QSL Package Worksheet with supporting information, by 5 PM Philadelphia time on 14 November 2024. Products must meet stringent compliance criteria, including being manufactured in Trade Agreements Act (TAA) compliant countries and not containing natural rubber latex. The DHA anticipates establishing the QSL by 14 December 2024, at which point qualified vendors will be invited to submit pricing. The estimated annual sales volume for these products is approximately $908,392, and vendors should note that successful inclusion in the QSL does not guarantee sales volume. This process emphasizes adherence to FDA regulations and quality assurance for medical supplies within the Department of Defense's Medical/Surgical Prime Vendor Program.
    QSL Package Worksheet MN-2407-40 CHG APPLICATORS SURGICAL.xlsx
    The document outlines the eligibility criteria for vendors aiming to qualify for the Qualified Supplier List (QSL) related to the supply of Chlorhexidine Gluconate (CHG) Applicators for the Department of Defense (DoD). Key requirements include having a DAPA number or applying for one, a valid agreement with the DoD Medical/Surgical Prime Vendor, and an active CAGE Code registered with the System for Award Management (SAM). Vendors must provide detailed product specifications, including manufacturer part numbers, and evidence of compliance with safety regulations, such as FDA approvals and packaging that meets ISO standards. The submission must include supporting documentation to validate claims regarding product sterility, flammability warnings, and expiration dates. Failure to meet these criteria or to provide comprehensive documentation will disqualify vendors from consideration. The emphasis is on technical compliance to ensure the safety and efficacy of medical supplies, reflecting the stringent requirements inherent in government procurement processes. Overall, the document emphasizes the need for detailed responses and documentation to ensure supplier credibility within government contracts.
    Lifecycle
    Title
    Type
    Chlorhexidine Gluconate (CHG) Applicators, Surgical
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Cloth, Chlorhexidine Gluconate Pre-Op Prep
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cloth, Chlorhexidine Gluconate Pre-Op Prep products, with a presolicitation notice expected to be released on or about February 2, 2025. This initiative aims to solicit information and evaluate products such as single-use, rinse-free cloths pre-saturated with 2% Chlorhexidine Gluconate, which are essential for skin antisepsis prior to surgical procedures. Vendors interested in participating must have a Distribution and Pricing Agreement (DAPA) and ensure their products are manufactured in a Trade Agreements Act (TAA) compliant country, with all relevant details to be made available on the SAM.gov website upon the QSL announcement. For further inquiries, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Specimen Container Peel Pack
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors for the Qualified Suppliers Listing (QSL) for Specimen Container Peel Pack products intended for use in Military Treatment Facilities and operational assemblages. Vendors must possess or apply for a Distribution and Pricing Agreement (DAPA) number, maintain active registration with the System for Award Management (SAM), and have agreements with DoD Medical/Surgical Prime Vendors such as Cardinal Health and Owens & Minor. This initiative is crucial for standardizing medical supplies within the Military Health System, ensuring compliance with quality standards and regulations, including the Trade Agreements Act (TAA). Interested vendors should submit their QSL Package Worksheet and supporting documentation by August 1, 2024, and can direct inquiries to Cornelius Brother at cornelius.l.brothers.ctr@health.mil or Moises Soto at moises.soto1.ctr@health.mil.
    Vaginal Specula Disposable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Disposable Vaginal Specula. This initiative aims to solicit information and products for evaluation, focusing on single-use, sterile and non-sterile Pederson style vaginal specula in various sizes, which will be utilized in outpatient OB/GYN, emergency department, or urgent care settings, excluding surgical procedures. Interested vendors must have or be in the process of obtaining a Distribution and Pricing Agreement (DAPA) and ensure compliance with the Trade Agreements Act (TAA), with the QSL Announcement expected to be released on or about February 2, 2025. For further inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or the MMESO Enterprise Wide Standardization at dha.detrick.med-log.mbx.mmeso@mail.mil.
    Cricothyrotomy Kits
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Cricothyrotomy Kits, with a presolicitation notice expected to be released on or about December 5, 2024. The procurement aims to identify vendors capable of supplying single-use emergent surgical cricothyrotomy kits that meet specific technical requirements, including a cuffed and flanged airway and various surgical instruments, while ensuring compliance with the Trade Agreements Act (TAA). These kits are critical for emergency medical procedures, emphasizing the importance of having reliable and standardized medical supplies available for military personnel. Interested vendors must ensure they have an active account in the System for Award Management (SAM) and a Distribution and Pricing Agreement (DAPA) in place, with further details to be provided in the forthcoming QSL Announcement. For inquiries, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil.
    Skin Staplers
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for Skin Staplers, with a presolicitation notice expected to be released on or about February 9, 2025. This initiative aims to solicit information and products for evaluation, focusing on sterile, single patient use skin staplers designed for external skin closure, while excluding reloadable, reprocessed, absorbable, or rotating head staplers. The selected products must comply with the Trade Agreements Act (TAA) and be manufactured in compliant countries, with all vendors required to have a Distribution and Pricing Agreement (DAPA) and an active account in the System for Award Management (SAM). For further details, interested parties can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil or refer to the DLA website for additional information regarding the MSPV program.
    Non-Reinforced Heat Reflective Shell – Hypothermia Prevention
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is preparing to establish a Qualified Suppliers Listing (QSL) for the MD-2409-56 Non-Reinforced Heat Reflective Shell, aimed at hypothermia prevention in non-hospital settings. This initiative seeks to identify and evaluate products designed to envelop patients suffering from hypothermia, with specifications including materials such as Bi-axially-oriented polyethylene terephthalate (BoPET) and options for both active and passive heat sources. The QSL will facilitate the procurement of these critical medical supplies, which must comply with Trade Agreements Act (TAA) regulations and be manufactured in compliant countries. Interested vendors should ensure they have an active Distribution and Pricing Agreement (DAPA) and are registered in the System for Award Management (SAM) to participate. For further details, vendors can contact Tara J. Perrien, Contracting Officer, at tara.perrien@dla.mil, and should monitor the SAM.gov website for the forthcoming QSL Announcement expected around December 12, 2024.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Knee Sleeves, Hinged
    Active
    Dept Of Defense
    The US Department of Defense, through the Defense Health Agency and Defense Logistics Agency, intends to establish a list of qualified suppliers for knee sleeves, hinged, for potential use by the military. These sleeves are designed to stabilize and support the knee joint, providing pain relief and are intended for single use. They are made from various materials, cater to different sizes, and feature hinge support while being free from natural rubber latex. The upcoming Qualified Suppliers Listing (QSL) will streamline the procurement process for these medical supplies, and vendors will need to have certain agreements in place to be eligible. The QSL Announcement is expected in November 2024, and responses to this notice are neither required nor encouraged at this time.
    Dimethyl Fumarate DR Presolicitation
    Active
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Active
    Dept Of Defense
    The Department of Defense (DoD) is seeking quotes for a Blanket Purchase Agreement (BPA) and Additional Discount Program (ADP) related to the procurement of pharmaceutical agents as part of its Uniform Formulary (UF) initiative. This procurement aims to establish an effective and integrated pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of newly approved drugs, including neurological agents, antibiotics, oncological agents, and various other pharmaceutical categories. Interested manufacturers must submit their quotes by January 16, 2025, with a pre-quotation teleconference scheduled for January 8, 2025, to discuss the requirements and expectations. For further inquiries, manufacturers can contact Tracy Banks at tracy.e.banks2.civ@health.mil or Patricia Tyson at patricia.a.tyson3.ctr@health.mil.